tti-101
Showing 1 - 7 of 7
Pancreatic Cancer Trial in Aurora (TTI-101)
Not yet recruiting
- Pancreatic Cancer
- TTI-101
-
Aurora, ColoradoUniversity of Colorado
Nov 30, 2023
Idiopathic Pulmonary Fibrosis Trial (TTI-101, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- TTI-101
- Placebo
- (no location specified)
Jan 3, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Control Group
- TTI-101
-
Houston, TexasM D Anderson Cancer Centerl
Apr 25, 2023
Breast Cancer Trial in Canton (TTI-101, Palbociclib, Aromatase inhibitor (AI))
Recruiting
- Breast Cancer
- TTI-101
- +2 more
-
Saint Louis, Missouri
- +2 more
Jan 12, 2023
Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- TTI-101
- Pembrolizumab
- (no location specified)
Dec 20, 2022
Hepatocellular Carcinoma Trial (TTI-101, Pembrolizumab, Atezolizumab)
Not yet recruiting
- Hepatocellular Carcinoma
- TTI-101
- +3 more
- (no location specified)
Jun 30, 2022
Breast Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer Trial in Atlanta, Houston, San Antonio
Recruiting
- Breast Cancer
- +7 more
- TTI-101
-
Atlanta, Georgia
- +2 more
Jun 13, 2022